The Polycomb group protein EZH2 directly controls DNA methylation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function. The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins and the DNA methylation systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 (Enhancer of Zeste homolog 2) interacts-within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3)-with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neither did Dnmt3a, another chromatin modifying enzyme that is a PRC2 component and is frequently genetically inactivated in myeloid neoplasms (Fig. 5) (31”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [32]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A., Wild, B., Miller, E. L., O'Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,562
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,533
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase
Jackson, J. P., Lindroth, A. M., Cao, X., & Jacobsen, S. E. (2002) · Nature · doi:10.1038/nature731 · Cited by 1,251
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Role of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,195
Cited by
Items 501–600 of 1,004
Faryna, M., Konermann, C., Aulmann, S., Bermejo, J. L., Brugger, M., Diederichs, S., Rom, J., Weichenhan, D., Claus, R., Rehli, M., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-209502 · Cited by 99
Regulation of DNA Methylation Patterns by CK2-Mediated Phosphorylation of Dnmt3a
Deplus, R., Blanchon, L., Rajavelu, A., Boukaba, A., Defrance, M., Luciani, J., Rothé, F., Dedeurwaerder, S., Denis, H., Brinkman, A. B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.048 · Cited by 100
Self-citationGene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia
Grubach, L., Juhl‐Christensen, C., Rethmeier, A., Olesen, L. H., Aggerholm, A., Hokland, P., & Østergaard, M. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01083.x · Cited by 100
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer
Huqun, Ishikawa, R., Zhang, J., Miyazawa, H., Goto, Y., Shimizu, Y., Hagiwara, K., & Koyama, N. (2011) · Cancer · doi:10.1002/cncr.26441 · Cited by 98
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
Uribe‐Lewis, S., Stark, R., Carroll, T., Dunning, M., Bachman, M., Ito, Y., Stojic, L., Halim, S., Vowler, S. L., Lynch, A. G., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0605-5 · Cited by 99
Self-citationRank, G., Cerruti, L., Simpson, R. J., Moritz, R. L., Jane, S. M., & Zhao, Q. (2010) · Blood · doi:10.1182/blood-2009-10-251116 · Cited by 95
Ko, C., Hsu, H., Shen, M., Chang, W., & Wang, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804029200 · Cited by 98
Epigenetics of Cancer Progression
Vucic, E. A., Brown, C. J., & Lam, W. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.2.215 · Cited by 99
Hoffmann, M. J., Engers, R., Florl, A. R., Otte, A. P., Müller, M., & Schulz, W. A. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.9.4542 · Cited by 97
Polycomb Target Genes Are Silenced in Multiple Myeloma
Kalushkova, A., Fryknäs, M., Lemaire, M., Fristedt, C., Agarwal, P., Eriksson, M., Deleu, S., Atadja, P. W., Österborg, A., Nilsson, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011483 · Cited by 97
Rzehak, P., Saffery, R., Reischl, E., Covic, M., Wahl, S., Grote, V., Xhonneux, A., Langhendries, J.-P., Ferre, N., Closa-Monasterolo, R., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155554 · Cited by 91
Mohammad, H. P., Cai, Y., McGarvey, K. M., Easwaran, H., Van Neste, L., Ohm, J. E., O'Hagan, H. M., & Baylin, S. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0065 · Cited by 86
Non-canonical functions of the DNA methylome in gene regulation
Reddington, J. P., Pennings, S., & Meehan, R. R. (2013) · Biochemical Journal · doi:10.1042/bj20121585 · Cited by 77
A Mechanistic View of Genomic Imprinting
Sha, K. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.122007.110031 · Cited by 79
Epigenetic reprogramming modulates malignant properties of human liver cancer
Raggi, C., Factor, V. M., Seo, D., Holczbauer, Á., Gillen, M. C., Marquardt, J. U., Andersen, J. B., Durkin, M. E., & Thorgeirsson, S. S. (2014) · Hepatology · doi:10.1002/hep.27026 · Cited by 96
Zhuang, J., Peng, W., Li, H., Wang, W. T., Wei, Y., Li, W., & Xu, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047193 · Cited by 98
Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia
Bohl, S., Bullinger, L., & Rücker, F. G. (2018) · Expert Review of Hematology · doi:10.1080/17474086.2018.1453802 · Cited by 96
Monk, D., Wagschal, A., Arnaud, P., Müller, P.-S., Parker-Katiraee, L., Bourc’his, D., Scherer, S. W., Feil, R., Stanier, P., & Moore, G. E. (2008) · Genome Research · doi:10.1101/gr.077115.108 · Cited by 87
Transcriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
Chromatin modifiers and the promise of epigenetic therapy in acute leukemia
Greenblatt, S. M., & Nimer, S. D. (2014) · Leukemia · doi:10.1038/leu.2014.94 · Cited by 77
Vantaku, V., Putluri, V., Bader, D. A., Maity, S., Ma, J., Arnold, J. M., Rajapakshe, K., Donepudi, S. R., von Rundstedt, F.-C., Devarakonda, V., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0902-7 · Cited by 95
Veazey, K. J., Parnell, S. E., Miranda, R. C., & Golding, M. C. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0031-7 · Cited by 81
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas
Lue, J. K., Prabhu, S. A., Liu, Y., Gonzalez, Y., Verma, A., Mundi, P. S., Abshiru, N. A., Camarillo, J. M., Mehta, S., Chen, E. I., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3989 · Cited by 95
Li, J., Song, P., Jiang, T., Dai, D., Wang, H., Sun, J., Zhu, L., Xu, W., Feng, L., Shin, V. Y., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.014 · Cited by 95
The Role of Host Cell DNA Methylation in the Immune Response to Bacterial Infection
Qin, W., Scicluna, B. P., & van der Poll, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696280 · Cited by 95
DNA Methylation in Cancer: A Gene Silencing Mechanism and the Clinical Potential of Its Biomarkers
Fukushige, S., & Horii, A. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.229.173 · Cited by 94
Kwon, M. J., Kim, S.-S., Choi, Y.-L., Jung, H. S., Balch, C., Kim, S.-H., Song, Y.-S., Marquez, V. E., Nephew, K. P., & Shin, Y. K. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp336 · Cited by 87
The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing
Nuytten, M., Beke, L., Eynde, A. V., Ceulemans, H., Beullens, M., Hummelen, P. V., Fuks, F., & Bollen, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210774 · Cited by 94
Self-citationSzyf, M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr024 · Cited by 95
EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
Yi, X., Guo, J., Guo, J., Sun, S., Yang, P., Wang, J., Li, Y., Xie, L., Cai, J., & Wang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-03362-z · Cited by 94
Ras regulation of DNA-methylation and cancer
Patra, S. K. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.012 · Cited by 93
Common non-epigenetic drugs as epigenetic modulators
Lötsch, J., Schneider, G., Reker, D., Parnham, M. J., Schneider, P., Geißlinger, G., & Doehring, A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.08.006 · Cited by 93
Epigenomics of cancer – emerging new concepts
Hassler, M. R., & Egger, G. (2012) · Biochimie · doi:10.1016/j.biochi.2012.05.007 · Cited by 95
Variations in DNA Methylation Patterns During the Cell Cycle of HeLa Cells
Brown, S. E., Fraga, M. F., Weaver, I. C. G., Berdasco, M., & Szyf, M. (2007) · Epigenetics · doi:10.4161/epi.2.1.3880 · Cited by 93
Self-citationEZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells
Zhao, Y., Wang, X., Wu, W., Long, H., Huang, J., Wang, Z., Li, T., Tang, S., Zhu, B., & Chen, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.039 · Cited by 92
Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
Fan, T.-Y., Wang, H., Peng, X., Liu, Y., Li, H., Lei, B., Yu, M., & Qi, S. (2014) · PubMed · Cited by 92
Zhou, W. J., Tian, D., He, J., Zhang, L., Tang, X., Zhang, L., Wang, Y., Li, L., Zhao, J., Yuan, X., et al. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.04.010 · Cited by 92
Maternal effect genes: Findings and effects on mouse embryo development
Kim, K., & Lee, K. (2014) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2014.41.2.47 · Cited by 91
Lee, E. R., Murdoch, F. E., & Fritsch, M. K. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0203 · Cited by 79
Han, T., Jiao, F., Hu, H. X., Yuan, C., Wang, L., Jin, Z., Song, W., & Wang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7156 · Cited by 91
Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
Zhang, Q., Dong, P., Liu, X., Sakuragi, N., & Guo, S.-W. (2017) · Scientific Reports · doi:10.1038/s41598-017-06920-7 · Cited by 88
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
Hirukawa, A., Smith, H. W., Zuo, D., Dufour, C. R., Savage, P., Bertos, N., Johnson, R. M., Bui, T., Bourque, G., Basik, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04864-8 · Cited by 92
Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
Bewersdorf, J. P., Shallis, R. M., Stahl, M. F., & Zeidan, A. M. (2019) · Therapeutic Advances in Hematology · doi:10.1177/2040620718816698 · Cited by 91
Wu, K., Jiang, Y., Zhou, W., Zhang, B., Li, Y., Xie, F., Zhang, J., Wang, X., Yan, M., Xu, Q., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.02.006 · Cited by 90
Bugide, S., Gupta, R., Green, M. R., & Wajapeyee, N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102718118 · Cited by 90
Grimaldi, G., Christian, M., Steel, J. H., Henriet, P., Poutanen, M., & Brosens, J. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1139 · Cited by 84
Zapata, J. C., Campilongo, F., Barclay, R. A., DeMarino, C., Iglesias-Ussel, M. D., Kashanchi, F., & Romerio, F. (2017) · Virology · doi:10.1016/j.virol.2017.03.002 · Cited by 84
Bisphenol AF compromises blood-testis barrier integrity and sperm quality in mice
Wu, D., Huang, C., Jiao, X., Ding, Z., Zhang, S.-X., Miao, Y., & Huo, L. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.124410 · Cited by 91
Ochiai, H., Takenobu, H., Nakagawa, A., Yamaguchi, Y., Kimura, M., Ohira, M., Okimoto, Y., Fujimura, Y., Koseki, H., Kohno, Y., et al. (2010) · Oncogene · doi:10.1038/onc.2010.22 · Cited by 94
Common features of chromatin in aging and cancer: cause or coincidence?
Zane, L., Sharma, V., & Misteli, T. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.001 · Cited by 79
Zheng, Y., Wang, Z., Wei, S., Liu, Z., & Chen, G. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.034 · Cited by 89
Wang, Y., Lei, Y., Hu, Z.-L., Fang, Y.-F., Shen, Y., Song, M., & Chen, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05169-x · Cited by 88
Hinshelwood, R. A., Huschtscha, L. I., Melki, J. R., Stirzaker, C., Abdipranoto, A., Vissel, B., Ravasi, T., Wells, C. A., Hume, D. A., Reddel, R. R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1284 · Cited by 88
Molecular mechanisms of genomic imprinting and clinical implications for cancer
Uribe‐Lewis, S., Woodfine, K., Stojic, L., & Murrell, A. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001717 · Cited by 91
Epigenetic pathways through which experiences become linked with biology
McGowan, P. O., & Roth, T. L. (2015) · Development and Psychopathology · doi:10.1017/s0954579415000206 · Cited by 72
DNA N6-methyladenine in metazoans: functional epigenetic mark or bystander?
Luo, G.-Z., & He, C. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3412 · Cited by 87
Jeltsch, A., Broche, J., & Bashtrykov, P. (2018) · Genes · doi:10.3390/genes9110566 · Cited by 73
Phytochemicals in cancer prevention: modulating epigenetic alterations of DNA methylation
Pop, S., Enciu, A., Ţârcomnicu, I., Gille, E., & Tănase, C. (2019) · Phytochemistry Reviews · doi:10.1007/s11101-019-09627-x · Cited by 87
Gu, T., Hao, D., Woo, J., Huang, T.-W., Guo, L., Lin, X., Guzman, A. G., Tovy, A., Rosas, C., Jeong, M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01063-6 · Cited by 87
Lessons from senescence: Chromatin maintenance in non-proliferating cells
Rai, T. S., & Adams, P. D. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.07.014 · Cited by 71
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
Cárdenas, H., Zhao, J., Vieth, E., Nephew, K. P., & Matei, D. E. (2016) · Oncotarget · doi:10.18632/oncotarget.11497 · Cited by 88
Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects
Hatmal, M. M., Al-Hatamleh, M. A. I., Olaimat, A. N., Alshaer, W., Hasan, H., Albakri, K. A., Alkhafaji, E., Issa, N. N., Al‐Holy, M., Abderrahman, S. M., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10061219 · Cited by 87
CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus
Rodríguez, C., Borgel, J., Court, F., Cathala, G., Forné, T., & Piette, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.159 · Cited by 86
A Concise Review on Epigenetic Regulation: Insight into Molecular Mechanisms
Golbabapour, S., Abdulla, M. A., & Hajrezaei, M. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12128661 · Cited by 86
Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Tang, M., Xu, W., Wang, Q., Xiao, W., & Xu, R. (2009) · Current Genomics · doi:10.2174/138920209788920994 · Cited by 80
Cao, W., Ribeiro, R. D. O., Liu, D., Saintigny, P., Xia, R., Xue, Y., Lin, R., Mao, L., & Ren, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052984 · Cited by 86
Kodach, L. L., Jacobs, R. J., Heijmans, J., van Noesel, C. J. M., Langers, A. M. J., Verspaget, H. W., Hommes, D. W., Offerhaus, G. J. A., van den Brink, G. R., & Hardwick, J. C. H. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq147 · Cited by 82
Epigenetic regulation of satellite cell activation during muscle regeneration
Dilworth, F., & Blais, A. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt59 · Cited by 72
EZH2: a pivotal regulator in controlling cell differentiation.
Chen, Y.-H., Hung, M., & Li, L. (2012) · Europe PMC (PubMed Central) · Cited by 86
Park, H.-J., Choi, Y.-J., Kim, J. W., Chun, H.-S., Im, I., Yoon, S., Han, Y.-M., Song, C.-W., & Kim, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132992 · Cited by 79
EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation
Song, S., Zhang, R., Mo, B., Chen, L., Liu, L., Yu, Y., Cao, W., Fang, G., Wan, Y., Gu, Y., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.08.003 · Cited by 85
The Use of Conformational Restriction in Medicinal Chemistry
Pinheiro, P. D. S. M., Rodrigues, D. A., Maia, R. D. C., Thota, S., & Fraga, C. A. M. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190712205025 · Cited by 85
Baker, T., Nerle, S., Pritchard, J., Zhao, B., Rivera, V. M., Garner, A., & Gonzalvez, F. (2015) · Oncotarget · doi:10.18632/oncotarget.5066 · Cited by 78
Lsh controls Hox gene silencing during development
Xi, S., Zhu, H., Xu, H., Schmidtmann, A., Geiman, T. M., & Muegge, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703669104 · Cited by 71
Periyasamy, P., Bidasee, K. R., & Shinohara, T. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.01.021 · Cited by 85
Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer
Pathiraja, T. N., Nayak, S. R., Xi, Y., Jiang, S., Garee, J. P., Edwards, D. P., Lee, A. V., Chen, J., Shea, M. J., Santen, R. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008326 · Cited by 85
Fang, C., Qiao, Y., Mun, S. H., Lee, M. J., Murata, K., Bae, S., Zhao, B., Park‐Min, K., & Ivashkiv, L. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501466 · Cited by 85
Epigenomic Regulation of Schwann Cell Reprogramming in Peripheral Nerve Injury
Ma, K. H., Hung, H. A., & Svaren, J. P. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1370-16.2016 · Cited by 85
Hong, L. K., Chen, Y., Smith, C. C., Montgomery, S. A., Vincent, B. G., Dotti, G., & Savoldo, B. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0065 · Cited by 85
Xu, S., Xu, Y., Yin, M., Zhang, S., Liu, P., Koroleva, M., Si, S., Little, P. J., Pelisek, J., & Jin, Z. G. (2018) · Theranostics · doi:10.7150/thno.21966 · Cited by 85
Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries
Wongtrakoongate, P. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.137 · Cited by 84
Kaur, G., Rathod, S. S. S., Ghoneim, M. M., Alshehri, S., Ahmad, J., Mishra, A., & Alhakamy, N. A. (2022) · Biology · doi:10.3390/biology11010090 · Cited by 84
Tiffen, J. C., Gunatilake, D., Gallagher, S. J., Gowrishankar, K., Heinemann, A., Cullinane, C. M., Dutton‐Regester, K., Pupo, G. M., Strbenac, D., Yang, J. Y. H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4809 · Cited by 84
Zhao, L., Sun, M.-A., Li, Z., Bai, X., Yu, M., Wang, M., Liang, L., Shao, X., Arnovitz, S., Wang, Q., et al. (2014) · Genome Research · doi:10.1101/gr.163147.113 · Cited by 84
Identification of preferential target sites for human DNA methyltransferases
Choi, S. H., Heo, K., Byun, H., An, W., Lu, W., & Yang, A. S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq774 · Cited by 84
Metsuyanim, S., Pode-Shakked, N., Schmidt-Ott, K. M., Keshet, G., Rechavi, G., Blumental, D., & Dekel, B. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0322 · Cited by 80
Belinsky, S. A., Grimes, M. J., Picchi, M. A., Mitchell, H. D., Stidley, C. A., Tesfaigzi, Y., Channell, M. M., Liu, Y., Casero, R. A., Baylin, S. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3184 · Cited by 84
Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
Kwon, M. J., & Shin, Y. K. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12020983 · Cited by 84
Cao, W., Younis, R. H., Li, J., Chen, H., Xia, R., Mao, L., Chen, W., & Ren, H. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0130 · Cited by 84
Epigenomic drivers of immune dysfunction in aging
Keenan, C. R., & Allan, R. S. (2019) · Aging Cell · doi:10.1111/acel.12878 · Cited by 76
Wang, Z., & Yang, C. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.01.002 · Cited by 85
Control of cytokine gene transcription in Th1 and Th2 cells
Bowen, H., Kelly, A., Lee, T., & Lavender, P. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03067.x · Cited by 84
Biological Functions of DNA Methyltransferase 1 Require Its Methyltransferase Activity
Damelin, M. I., & Bestor, T. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00036-07 · Cited by 84
Rush, M., Appanah, R., Lee, S., Lam, L. L., Goyal, P., & Lorincz, M. C. (2009) · Epigenetics · doi:10.4161/epi.4.6.9392 · Cited by 83
Kofink, D., Boks, M. P. M., Timmers, H. T. M., & Kas, M. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.020 · Cited by 83
Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells
Murphy, P. J., Cipriany, B. R., Wallin, C. B., Ju, C. Y., Szeto, K., Hagarman, J. A., Benitez, J. J., Craighead, H. G., & Soloway, P. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218495110 · Cited by 80
Nutrition, Epigenetic Mechanisms, and Human Disease
Maulik, N., & Maulik, G. (2010) · CRC Press eBooks · doi:10.1201/b10449 · Cited by 83
DNA methylation processes in atherosclerotic plaque
Aavik, E., Babu, M., & Ylä‐Herttuala, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.006 · Cited by 83
Zhang, Y., Tang, B., Song, J. H., Yu, S., Yang, L., Su, H., & He, S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1106-2 · Cited by 83
RetractedHistone Modification Therapy of Cancer
Biancotto, C., Frigè, G., & Minucci, S. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60013-7 · Cited by 86
Metadata
- Authors
- Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., & Fuks, F.
- Affiliations
- Université Libre de Bruxelles (BE)
- Spanish National Cancer Research Centre (ES)
- KU Leuven (BE)
- Corresponding author
- Fuks, François
- ORCID
- Venue
- Nature
- Published
- 2005-12-14
- Volume
- 439
- Issue
- 7078
- Pages
- 871-874
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053421436
- Cited by
- 2,204
- References
- 27
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 60 · 2023: 72 · 2022: 89 · 2021: 110 · 2020: 95 · 2019: 94 · 2018: 95 · 2017: 119 · 2016: 151 · 2015: 134 · 2014: 128 · 2013: 135 · 2012: 164
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-04-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Fédération Wallonie-Bruxelles
- Fondation pour la Recherche Médicale
- Ministerio de Economía y Competitividad
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- EZH2, Polycomb group proteins, DNA methylation, DNA methyltransferases, polycomb repressive complex 2, epigenetic silencing, chromatin repression, promoter methylation, protein-protein interaction
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, HeLa Cells, Humans, Promoter Regions, Genetic, Protein Binding, Repressor Proteins, Substrate Specificity, Transcription Factors, CpG Islands, DNA Methylation, Gene Silencing, Epigenesis, Genetic, Chromatin Immunoprecipitation, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.